
Danish pharma major Novo Nordisk (NOV: N) has reportedly been subject to ransom claims from two hacker groups, which separately sought multimillion-dollar ransom payments after gaining unauthorized access to a limited number of internal IT systems.
The company disclosed the security incident on June 11, saying certain personal data had been accessed. It has since said its core business operations remain “up and running,” although some internal systems were temporarily taken offline while it responds to the breach.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze